Payment overview · 2025
General Payments
2 reported records · 2 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Internal Medicine · WINSTON SALEM, NC · NPI 1093773699
Verified facts
CMS Open Payments records show Gregory Michael Bugaj, MD received $231.83 in general payments during 2025 across 2 reported records.
Neurocrine BioSciences, Inc. accounted for 60.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
2 reported records · 2 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $139.56 | 60.2% | 1 | 2025 |
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $92.27 | 39.8% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $231.83 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $139.56 | 1 | 2025 |
Source payment records
|
|||||
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $92.27 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 697 | 116 |
| Gabapentin | Gabapentin | 420 | 76 |
| Amlodipine Besylate | Amlodipine Besylate | 419 | 66 |
| Furosemide | Furosemide | 408 | 71 |
| Levothyroxine Sodium | Levothyroxine Sodium | 358 | 55 |
| Potassium Chloride | Potassium Chloride | 344 | 59 |
| Eliquis | Apixaban | 307 | 53 |
| Trazodone Hcl | Trazodone Hcl | 289 | 54 |
| Tamsulosin Hcl | Tamsulosin Hcl | 272 | 45 |
| Sertraline Hcl | Sertraline Hcl | 264 | 53 |
| Levetiracetam | Levetiracetam | 259 | 36 |
| Omeprazole | Omeprazole | 230 | 37 |
| Pantoprazole Sodium | Pantoprazole Sodium | 227 | 42 |
| Clopidogrel | Clopidogrel Bisulfate | 225 | 34 |
| Metoprolol Succinate | Metoprolol Succinate | 224 | 34 |
| Famotidine | Famotidine | 223 | 34 |
| Mirtazapine | Mirtazapine | 215 | 43 |
| Metformin Hcl | Metformin Hcl | 192 | 31 |
| Donepezil Hcl | Donepezil Hcl | 184 | 33 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 178 | 28 |
| Lisinopril | Lisinopril | 169 | 29 |
| Carvedilol | Carvedilol | 158 | 22 |
| Metoprolol Tartrate | Metoprolol Tartrate | 141 | 27 |
| Quetiapine Fumarate | Quetiapine Fumarate | 141 | 29 |
| Losartan Potassium | Losartan Potassium | 138 | 27 |
| Memantine Hcl | Memantine Hcl | 133 | 19 |
| Januvia | Sitagliptin Phosphate | 115 | 13 |
| Baclofen | Baclofen | 108 | 20 |
| Duloxetine Hcl | Duloxetine Hcl | 104 | 19 |
| Hydralazine Hcl | Hydralazine Hcl | 102 | 21 |
| Prednisone | Prednisone | 102 | 32 |
| Jardiance | Empagliflozin | 97 | 12 |
| Risperidone | Risperidone | 89 | 12 |
| Divalproex Sodium | Divalproex Sodium | 84 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 84 | 19 |
| Rivastigmine | Rivastigmine Tartrate | 78 | suppressed |
| Finasteride | Finasteride | 72 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 70 | 13 |
| Escitalopram Oxalate | Escitalopram Oxalate | 67 | 15 |
| Latanoprost | Latanoprost | 67 | 21 |
| Xarelto | Rivaroxaban | 67 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 65 | 13 |
| Olanzapine | Olanzapine | 61 | 12 |
| Brimonidine Tartrate | Brimonidine Tartrate | 60 | 14 |
| Lorazepam | Lorazepam | 60 | 23 |
| Metformin Hcl Er | Metformin Hcl | 60 | 12 |
| Lamotrigine | Lamotrigine | 57 | suppressed |
| Ezetimibe | Ezetimibe | 55 | suppressed |
| Aripiprazole | Aripiprazole | 53 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 53 | 32 |
| Anastrozole | Anastrozole | 51 | suppressed |
| Spironolactone | Spironolactone | 51 | 11 |
| Allopurinol | Allopurinol | 50 | 14 |
| Benztropine Mesylate | Benztropine Mesylate | 50 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 50 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 50 | 13 |
| Buspirone Hcl | Buspirone Hcl | 49 | suppressed |
| Valsartan | Valsartan | 48 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 46 | 16 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 46 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 46 | suppressed |
| Glipizide | Glipizide | 43 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 43 | 37 |
| Cephalexin | Cephalexin | 41 | 22 |
| Primidone | Primidone | 40 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 38 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 38 | 19 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 37 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 36 | 18 |
| Albuterol Sulfate | Albuterol Sulfate | 35 | 15 |
| Linzess | Linaclotide | 34 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 33 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 33 | 20 |
| Oxycodone Hcl | Oxycodone Hcl | 32 | 13 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 32 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 31 | suppressed |
| Permethrin | Permethrin | 31 | 17 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 31 | 13 |
| Bumetanide | Bumetanide | 30 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 29 | suppressed |
| Lactulose | Lactulose | 29 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 29 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 28 | 14 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 28 | suppressed |
| Nystatin | Nystatin | 28 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 28 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 27 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 27 | 13 |
| Ondansetron Odt | Ondansetron | 26 | 18 |
| Ozempic | Semaglutide | 26 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 25 | 19 |
| Haloperidol | Haloperidol | 25 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 24 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 24 | 20 |
| Budesonide | Budesonide | 24 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 24 | 11 |
| Meloxicam | Meloxicam | 24 | suppressed |
| Tradjenta | Linagliptin | 24 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 23 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 22 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 22 | suppressed |
| Atenolol | Atenolol | 21 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 21 | suppressed |
| Nyamyc | Nystatin | 21 | 13 |
| Rivastigmine | Rivastigmine | 20 | suppressed |
| Torsemide | Torsemide | 20 | suppressed |
| Calcitriol | Calcitriol | 19 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 19 | suppressed |
| Novolog Flexpen | Insulin Aspart | 19 | 12 |
| Amlodipine-Atorvastatin | Amlodipine/Atorvastatin | 18 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 18 | suppressed |
| Celecoxib | Celecoxib | 18 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 18 | 13 |
| Acetazolamide | Acetazolamide | 17 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 17 | suppressed |
| Bupropion Xl | Bupropion Hcl | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Glimepiride | Glimepiride | 17 | suppressed |
| Ketoconazole | Ketoconazole | 17 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 17 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 17 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 17 | suppressed |
| Travoprost | Travoprost | 17 | suppressed |
| Clonazepam | Clonazepam | 16 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Levofloxacin | Levofloxacin | 16 | 11 |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 15 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 15 | suppressed |
| Valproic Acid | Valproic Acid | 15 | suppressed |
| Alprazolam | Alprazolam | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 14 | suppressed |
| Cilostazol | Cilostazol | 14 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 14 | suppressed |
| Guanfacine Hcl Er | Guanfacine Hcl | 14 | suppressed |
| Insulin Lispro | Insulin Lispro | 14 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 14 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 13 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 13 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 13 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 13 | suppressed |
| Gemtesa | Vibegron | 13 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 13 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 13 | suppressed |
| Paricalcitol | Paricalcitol | 13 | suppressed |
| Tresiba | Insulin Degludec | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Simvastatin | Simvastatin | 12 | suppressed |
| Azithromycin | Azithromycin | 11 | suppressed |
| Carbamazepine | Carbamazepine | 11 | suppressed |
| Cartia Xt | Diltiazem Hcl | 11 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 11 | suppressed |
| Entresto | Sacubitril/Valsartan | 11 | suppressed |
| Lamotrigine Er | Lamotrigine | 11 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 11 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $231.83 · 2 records | Neurocrine BioSciences, Inc. | INGREZZA, NUPLAZID | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error